Patent details
EP4126237 Title: DIMALEATE FORM OF 1-((2R,4R)-2-(1H-BENZO[D]IMIDAZOL-2-YL)-1-METHYLPIPERIDIN-4-YL)-3-(4-CYANOPHENYL)UREA
Basic Information
- Publication number:
- EP4126237
- PCT Application Number:
- EP2021057575
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP217134154
- PCT Publication Number:
- WO2021191278
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- DIMALEATE FORM OF 1-((2R,4R)-2-(1H-BENZO[D]IMIDAZOL-2-YL)-1-METHYLPIPERIDIN-4-YL)-3-(4-CYANOPHENYL)UREA
- French Title of Invention:
- FORME DIMALÉATE DE 1-((2R,4R)-2-(1H-BENZO[D]IMIDAZOL-2-YL)-1-MÉTHYLPIPÉRIDINE?-4-YL)-3-(4-CYANOPHÉNYL)URÉE
- German Title of Invention:
- DIMALEATFORM VON 1-((2R,4R)-2-(1H-BENZO[D]IMIDAZOL-2-YL)-1-METHYLPIPERIDIN-4-YL)-3-(4-CYANOPHENYL)HARNSTOFF
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 03/05/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 16/05/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 10/04/2024
- Unitary Effect Registration Date:
- 16/05/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 24/03/2021
- Grant date:
- 10/04/2024
- EP Publication Date:
- 08/02/2023
- PCT Publication Date:
- 30/09/2021
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 10/04/2024
- EP B1 Publication Date:
- 10/04/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 24/03/2041
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 03/04/2024
- Name:
- LEK Pharmaceuticals d.d.
- Address:
- Verovskova 57, 1526 Ljubljana, Slovenia (SI)
Inventor
- Name:
- PEKLAR, Boris
- Address:
- Slovenia (SI)
Priority
- Priority Number:
- 20165898
- Priority Date:
- 26/03/2020
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- A61P 35/00; C07D 401/04; A61K 31/4178;
Publication
European Patent Bulletin
1
- Issue number:
- 202415
- Publication date:
- 10/04/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202424
- Publication date:
- 12/06/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202425
- Publication date:
- 19/06/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|